Sernova's Cell Pouch Shown to Provide a Safe Environment for Therapeutic Insulin Producing Islets in Humans with Type 1 Diabetes

Sernova announced that Dr. James Shapiro, principal investigator of the clinical study, presented encouraging safety and biocompatibility results for the Cell Pouch and, following islet transplant, proof of islet cell survival and the presence of insulin in the first two patients of an up-to-20-patient study.
FirstWord MedTech